Hygieia Announces “Open Access” to Research Article Demonstrating the Value of Automating Insulin Titration

Livonia, Mich., April 21, 2020 – Hygieia, developer of the d-Nav insulin management program, announced today the availability of one of its leading research papers on a topic associated with the effective clinical treatment of people with advanced Type 2 diabetes.

The paper, “Automated insulin dosing guidance to optimize insulin management in patients with Type 2 diabetes: a multicenter, randomized controlled trial,” was published March 16, 2019, in The Lancet.

The full text is now available, free, at this link: PubMed Central. The study reveals that: “… personalized, automated insulin titration provided by the d-Nav [program] along with dedicated HCP [health care professional] support generates superior glycemic control as compared to HCP support alone.”

Data from this study was discussed at a session of the 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019) in Berlin.

For more information on Hygieia’s d-Nav Insulin Management System, contact hygieia.com or 734-369-9980.

About Hygieia and the d-Nav Insulin Management Program

Hygieia’s d-Nav® insulin management program includes an AI-powered application and helps people with Type 2 diabetes use insulin in a safe and effective way. It works by guiding users to adjust their insulin doses – based on blood glucose patterns — every few days rather than three of four times annually. Studies show that some 90 percent of people using d-Nav® achieve lower A1c within three months. Patients report feeling better; having fewer complications; spending less time at their physician’s office; and potentially lowering their disease management costs. The d-Nav® insulin management program was developed by two University of Michigan researchers and has been peer-reviewed with studies published in leading medical journals. Hygieia is headquartered in Livonia, Michigan. Learn more at hygieia.com.

# # #

Media Contact:

Debbie Reinheimer, debbie@reinheimerpr.com, 248-227-3667

Kathy Bilitzke, kjbilitzke11@gmail.com, 248-980-4597